Cleared Traditional

K792354 - THE CIRCULATOR BOOT

K792354 is the FDA 510(k) clearance for THE CIRCULATOR BOOT by Circulator Boot Corp.. It is a Class 2 Cardiovascular device (product code DRN) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K792354 · Circulator Boot Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1980
Decision
50d
Days
Class 2
Risk

K792354 is an FDA 510(k) clearance for the THE CIRCULATOR BOOT. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Circulator Boot Corp. (Mchenry, US). The FDA issued a Cleared decision on January 9, 1980 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Circulator Boot Corp. devices

Submission Details

510(k) Number K792354 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 1979
Decision Date January 09, 1980
Days to Decision 50 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 125d · This submission: 50d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.